Novo Drops 3.2% As CEO Eyes Longevity And Aesthetics - Yahoo Finance
business 2026/06/08 17:26:18

Novo Drops 3.2% As CEO Eyes Longevity And Aesthetics - Yahoo Finance

Source:Yahoo Entertainment
Author:Khac Phu Nguyen

Novo’s CEO says semaglutide could push the company beyond obesity and diabetes into longevity and appearance-related medicine.